Literature DB >> 12688376

Human pancreatic acinar cells do not respond to cholecystokinin.

Baoan Ji1, Yan Bi, Diane Simeone, Richard M Mortensen, Craig D Logsdon.   

Abstract

Pancreatic secretion can be influenced by cholecystokinin (CCK) either directly via actions on acinar cells or indirectly via actions on nerves. The presence and functional roles of CCK receptors on human pancreatic acinar cells remains unclear. In the current study human pancreatic acini were isolated and then treated with CCK-8, gastrin and/or carbachol. Functional parameters were measured including intracellular [Ca2+] and amylase secretion. It was observed that human acini did not respond to CCK agonists but did respond to carbachol with robust increases in functional parameters. Adenoviral-mediated gene transfer of CCK1 or CCK2 receptors to the human cells resulted in cell responses to CCK agonists. In order to determine the reason for the lack of responsiveness of the human acini, expression of receptor mRNAs was determined using quantitative RT-PCR and localized by in situ hybridization. mRNA levels for CCK1 receptors were approximately 30 times lower than those of CCK2 receptors, which were approximately 10 times lower than those of m3 Ach receptors as measured by quantitative PCR. Neither CCK1 nor CCK2 receptors were localized in adult human pancreas by in situ hybridization. These results indicate that human pancreatic acinar cells do not respond directly to CCK receptor activation and this is likely due to an insufficient level of receptor expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12688376     DOI: 10.1034/j.1600-0773.2002.910610.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  8 in total

Review 1.  Molecular mechanism of pancreatic and salivary gland fluid and HCO3 secretion.

Authors:  Min Goo Lee; Ehud Ohana; Hyun Woo Park; Dongki Yang; Shmuel Muallem
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

2.  Cholecystokinin Receptor Antagonist Therapy Decreases Inflammation and Fibrosis in Chronic Pancreatitis.

Authors:  Sandeep Nadella; Victor Ciofoaia; Hong Cao; Bhaskar Kallakury; Robin D Tucker; Jill P Smith
Journal:  Dig Dis Sci       Date:  2019-10-09       Impact factor: 3.199

Review 3.  Cholecystokinin-induced satiety, a key gut servomechanism that is affected by the membrane microenvironment of this receptor.

Authors:  A J Desai; M Dong; K G Harikumar; L J Miller
Journal:  Int J Obes Suppl       Date:  2016-11-16

4.  Phenotypic changes in mouse pancreatic stellate cell Ca2+ signaling events following activation in culture and in a disease model of pancreatitis.

Authors:  Jong Hak Won; Yu Zhang; Baoan Ji; Craig D Logsdon; David I Yule
Journal:  Mol Biol Cell       Date:  2011-02-01       Impact factor: 4.138

5.  Animal models for investigating chronic pancreatitis.

Authors:  Alexander A Aghdassi; Julia Mayerle; Sandra Christochowitz; Frank U Weiss; Matthias Sendler; Markus M Lerch
Journal:  Fibrogenesis Tissue Repair       Date:  2011-12-01

6.  Cigarette toxin 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces experimental pancreatitis through α7 nicotinic acetylcholine receptors (nAChRs) in mice.

Authors:  A A Alahmari; B Sreekumar; V Patel; M Ashat; M Alexandre; A K Uduman; E O Akinbiyi; A Ceplenski; C A Shugrue; T R Kolodecik; N Tashkandi; S W Messenger; G E Groblewski; F S Gorelick; E C Thrower
Journal:  PLoS One       Date:  2018-06-05       Impact factor: 3.240

Review 7.  Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression.

Authors:  Jeremy S Wilson; Romano C Pirola; Minoti V Apte
Journal:  Front Physiol       Date:  2014-02-14       Impact factor: 4.566

8.  Pancreas-specific CHRM3 activation causes pancreatitis in mice.

Authors:  Jianhua Wan; Jiale Wang; Larry E Wagner; Oliver H Wang; Fu Gui; Jiaxiang Chen; Xiaohui Zhu; Ashley N Haddock; Brandy H Edenfield; Brian Haight; Debabrata Mukhopadhyay; Ying Wang; David I Yule; Yan Bi; Baoan Ji
Journal:  JCI Insight       Date:  2021-09-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.